A research team has discovered that C-reactive protein (CRP) can exacerbate kidney inflammation caused by diabetes, also known as diabetic kidney disease (DKD), through a Smad3-NLRP3 inflammasome-dependent mechanism. Therefore, future research targeting CRP or the Smad3-NLRP3 mechanism may provide new treatment directions for DKD. CRP is an inflammatory protein whose level rises rapidly when the body undergoes an inflammatory response, making it a commonly used clinical marker for inflammation. Recent studies have shown that CRP exacerbates kidney inflammation and fibrosis through the TGF-β/Smad3 signaling pathway, worsening DKD. The activation of the NLRP3 inflammasome is a key factor driving kidney inflammation,...